Dopamine Receptors and the Kidney: An Overview of Health- and Pharmacological-Targeted Implications by Alejandro Olivares-Hernández, Luis Figuero-Pérez, Juan Jesus Cruz-Hernandez, Rogelio González Sarmiento, Ricardo Usategui-Martin, José Pablo Miramontes-González

Get full text

Immune System Disorders, Cancer and Viral Infections: A New Treatment Opportunity for the Immune Checkpoint Inhibitors by Alejandro Olivares-Hernández, Luis Figuero-Pérez, José Pablo Miramontes-González, Álvaro López-Gutiérrez, Rogelio González-Sarmiento, Juan Jesús Cruz-Hernández, Emilio Fonseca-Sánchez

Get full text

Complications secondary to the use of SGLT2 inhibitors in oncological patients: a series of 5 cases by Luis Posado-Domínguez, Luis Figuero-Pérez, María Aranzazu Amores-Martin, Pablo Reguera-Puertas, María Martín-Galache, Edel Del Barco-Morillo, Emilio Fonseca-Sánchez

Get full text

Response to Treatment with an Anti-Interleukin-6 Receptor Antibody (Tocilizumab) in a Patient with Hemophagocytic Syndrome Secondary to Immune Checkpoint Inhibitors by Alejandro Olivares-Hernández, Luis Figuero-Pérez, María A. Amores Martín, Lorena Bellido Hernández, Laura Mezquita, María del Rosario Vidal Tocino, Félix López Cadenas, Felipe Gómez-Caminero López, Roberto A. Escala-Cornejo, Juan Jesús Cruz Hernández

Get full text

Influence of DNA Mismatch Repair (MMR) System in Survival and Response to Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC): Retrospective Analysis by Alejandro Olivares-Hernández, Edel del Barco Morillo, Carmen Parra Pérez, José Pablo Miramontes-González, Luis Figuero-Pérez, Teresa Martín-Gómez, Roberto Escala-Cornejo, Lorena Bellido Hernández, Rogelio González Sarmiento, Juan Jesús Cruz-Hernández, María Dolores Ludeña de la Cruz

Get full text